The forgotten type 2 diabetes mellitus medicine: rosiglitazone
Bo Xu, Aoxiang Xing, Shuwei Li
Topics & Concepts
RosiglitazoneMedicinePioglitazoneInsulin resistanceType 2 Diabetes MellitusDiabetes mellitusInternal medicineType 2 diabetesAdverse effectEndocrinologyThiazolidinedionePharmacologyPeroxisome Proliferator-Activated ReceptorsDiabetes Treatment and ManagementMetabolism, Diabetes, and Cancer